$Psyence Biomedical (PBM.US)$ Now zero shares available to borrow. 327%. Huge 13g news released. Psychedelics a hot new thing with RFKjr on board,companies surely could be given big dollar grants. Squeeze potential here.
$Mind Medicine (MNMD.US)$

$Mind Medicine (MNMD.US)$ close above ten and next week lit

$Conduit Pharmaceuticals (CDT.US)$ Buy Zone
(BZ) 2.41 - 2.59 dont be late to the party
$Mind Medicine (MNMD.US)$ next week is money
$Gran Tierra Energy (GTE.US)$ will be a RUNNER Soon agtet it bounces off the (4.91 - 5.19) range

$Mind Medicine (MNMD.US)$ still hold

$Aclarion (ACON.US)$  Get on board or get left behind on these (3)
$Nauticus Robotics (KITT.US)$
$Mind Medicine (MNMD.US)$

$Mind Medicine (MNMD.US)$
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
MindMed (NASDAQ: MNMD) has initiated Panorama, its second Phase 3 study of MM120 ODT (lysergide D-tartrate) for Generalized Anxiety Disorder (GAD), with the first patient now dosed. The study will evaluate a proprietary, pharmaceutically optimized form of LSD against placebo, enrolling approximately 250 participants across US and Europe.
The ...

$Mind Medicine (MNMD.US)$ Reuters· 2 mins ago.                               MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of Mm120 in Generalized Anxiety Disorder